 |
The Future of PharmaAuthor: Samir Gondalia, ISPE Boston
The Future of Pharma with ISPE Boston. Find out where the pharmaceutical industry is headed and what it means for you. Join host Samir Gondalia as he chats with the thought leaders of the pharma world about the new technologies, innovative applications and emerging markets and how it's going to influence the future of Pharma. Language: en Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Episode 41 - Holley Miller and Why Better Science Isn't Enough in Pharma
Wednesday, 21 October, 2026
My guest in today's episode is Holley Miller. Holley is the Founder and President of Grey Matter Marketing, where she helps life sciences CEOs engineer adoption before they ever sell a product. She has spent nearly two decades working with pre-commercial and growth-stage companies across medtech, pharma, and digital health, and her clients' results include a J&J acquisition and over $4.5 billion in enterprise value. In this interview, Holley Miller shares insights on why great healthcare products often fail despite strong science, emphasizing the importance of belief, behavior change, and strategic market positioning in pharma. The discussion covers how to engineer market adoption, the role of belief in clinical and consumer decision-making, and future trends in pharma commercialization. Key topics: Market adoption challenges in pharma The role of belief and behavior in healthcare decisions Strategies for successful product launch and scaling Having spend most of my career in drug development, this discussion around commercial launch was very educating for me. I enjoyed it a lot. Hope you do too. Here's Holley Miller.
